Guggenheim lowered the firm’s price target on Regeneron (REGN) to $950 from $1,200 and keeps a Buy rating on the shares. The firm, which is ...

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Margulies has joined the firm’s Equities Sales & Trading group as a ...

O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its target price increased by Guggenheim from $1,400.00 to $1,475.00 in a report released on Friday morning,Benzinga reports. Guggenheim currently ...

The Transpacific Exchange of the Game” will explore the longstanding exchange of teams and players in the more than 150 years ...

Works & Process at the Guggenheim, alongside a list of renowned artists, is developing new works on Vermont's Potash Hill.

Plus, the Jewish Federation of Cleveland received $90 million to support five Jewish day schools in the city, and $70 million ...

AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by stock analysts at Guggenheim from $212.00 to $214.00 in a ...

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule ...

Lendlease completed the $320M sale of its U.S. military housing portfolio to Centinel Public Partnerships, an affiliate of ...

The Guggenheim CEO and LA Dodgers owner committed $100 million to start LA Rises, which he will lead with Magic Johnson and ...